Myovant Sciences Ltd. - stock earnings
Stock symbol MYOV is outdated, potentially delisted? Maybe it is available on other exchange?
MYOV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -45.6 million USD | 104.8 million USD |
| 2022Q2 | -21.2 million USD | 116.5 million USD |
| 2022Q1 | -59.3 million USD | 57.6 million USD |
| 2021Q4 | -63.4 million USD | 54.4 million USD |
| 2021Q3 | -21.6 million USD | 77.9 million USD |
| 2021Q2 | -61.7 million USD | 41.1 million USD |
| 2021Q1 | -81.4 million USD | 24.6 million USD |
| 2020Q4 | -73.8 million USD | 1.4 million USD |
| 2020Q3 | -67.1 million USD | ? USD |
MYOV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -206.0 million USD | 231.0 million USD |
| 2021 | -255.1 million USD | 59.3 million USD |
| 2020 | -289.0 million USD | ? USD |
| 2019 | -273.6 million USD | ? USD |
| 2018 | -143.3 million USD | ? USD |
MYOV
Price: $26.98
52 week price:
Earnings Per Share: -0.92 USD
P/E Ratio: -7.04
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 539600
Ebitda: -41.0 millionMarket Capitalization: 2.6 billion